Healthy Living Arizona: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.

Press releases published on June 16, 2026

Jun. 16, 2026

Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study

Indeterminate GlobeNewswire

Jun. 16, 2026

Acronis e Eyetech, partner MSP, fanno parte dell'iniziativa #TeamUp per sensibilizzare i bambini di Malta alla sicurezza informatica

Indeterminate GlobeNewswire

Jun. 16, 2026

Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

AI-Driven Ion Exchange Materials Market Attracts $73M in Investment Funding as Water Treatment Digitization Accelerates

Indeterminate GlobeNewswire

Jun. 16, 2026

FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers

Indeterminate GlobeNewswire

Jun. 16, 2026

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research

Indeterminate GlobeNewswire

Jun. 16, 2026

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

Indeterminate GlobeNewswire

Jun. 16, 2026

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Indeterminate GlobeNewswire

Jun. 16, 2026

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

Indeterminate GlobeNewswire

Jun. 16, 2026

NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure

Indeterminate GlobeNewswire

Jun. 16, 2026

CDT Equity Announces Debt Update and New Loan Facility

Indeterminate GlobeNewswire

Jun. 16, 2026

Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

Indeterminate GlobeNewswire

Jun. 16, 2026

King Faisal Specialist Hospital Presents Robotic Surgery as a Model for Innovation-Driven Specialized Care at HLTH Europe 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

Das King Faisal Specialist Hospital präsentiert auf der HLTH Europe 2026 die Roboterchirurgie als Vorbild für innovationsgetriebene Spezialversorgung

Indeterminate GlobeNewswire

Jun. 16, 2026

Le King Faisal Specialist Hospital présente la chirurgie robotique comme modèle de soins spécialisés axés sur l’innovation lors du congrès HLTH Europe 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

Through the MUHC Foundation, one family helps fuel breakthrough in rare cancer research

Indeterminate GlobeNewswire

Jun. 16, 2026

Une famille soutient la recherche sur les cancers rares par l’intermédiaire de la Fondation du CUSM

Indeterminate GlobeNewswire

Jun. 16, 2026

ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome

Indeterminate GlobeNewswire

Jun. 16, 2026

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

Syncromune Presents Multi-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium

Indeterminate GlobeNewswire